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Abstract
Natural killer cells have well-established functions in immune defense against virus infections and
cancer through their cytolytic activity and production of cytokines. Herein, we examined the
frequency of NK cells and their influence on T cell responses in mice given variants of
lymphocytic choriomeningitis virus (LCMV) that cause acute or persisting infection. We found
increased frequencies of circulating NK cells during disseminating infection compared to
uninfected or acutely infected mice. Consistent with recent reports, we observed that the depletion
of NK cells in mice with disseminated infection increased peak numbers of virus-specific cytokine
producing CD8+ T cells and resulted in the rapid resolution of disseminated infection.
Additionally, we show that NK cell depletion sustained T cell responses across time and protected
against T cell exhaustion. The positive effects of NK cell depletion on T cell responses only
occurred when NK cells were depleted within the first two days of infection. We find that the
improved CD8+ T cell response correlated with an enhanced ability of APCs from NK cell-
depleted mice to stimulate T cell proliferation, independently of the effects of NK cells on CD4+
T cells. These results indicate that NK cells play an integral role in limiting the CD8 T cell
response and contribute to T cell exhaustion by diminishing APC function during persisting virus
infection.
Introduction
Diseases caused by chronic virus infections are a significant worldwide health problem.
When CD8+ T cells fail to eliminate infections, such as HIV and HCV, the viruses establish
persistent infection with pathological consequences. Despite the clear importance of T cells
in the control of these virus infections, recent data indicate that natural killer (NK) cells also
contribute to virus control or pathogenesis. Genetic polymorphisms within an inhibitory NK
cell receptor (KIR2DL3) and its ligand (HLA-C1) directly influence HCV resolution, while
immune pressure by NK cells has selected for HIV amino acid polymorphisms only in
individuals that encode the NK receptor KIR2DL2 (1-4). These studies highlight the
importance of NK cells during chronic viral infection.
NK cells are generally involved in innate immune defense against infections. NK cells
recognize certain target cells and mediate direct cytolysis of those cells and produce
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interferon to suppress virus replication (5). NK effector functions are controlled by a vast
array of activating and inhibitory receptors and cytotoxicity is initiated when the signals
from the activating receptors outweigh those from the inhibitory receptors. Cytokines, such
as IL-2, IL-15, and IFN-α/β, are potent activators of NK cells. Dendritic cells (DCs) are
important in activating NK cells through direct interactions and the production of NK-
activating cytokines. Intravital imaging shows that DCs and NK cells interact in lymph
nodes in vivo, and in vitro analyses demonstrate that DCs directly activate NK cells (6-9).
These NK-DC interactions are regulated by the NKp30 activating receptor, DNAM-1,
TNFα, as well as the trans-presentation of IL-15 by DCs (10-13). Thus, DCs are often a
critical cell type in the activation of NK cell responses.
NK-DC interactions also impact the functions of DCs. NK cells promote DC activity by
inducing their maturation, including the up-regulation of co-stimulatory molecules, and
increase DC production of IL-12 (6, 8, 14). However, NK cells can also directly lyse DCs or
decrease their antigen presentation functions (10, 15-17). Additionally, indirect effects
through NK cell-mediated lowering of the viral load can impact DC frequency (18).
Therefore, the effect of the NK-DC interactions on DCs is context dependent and can be
positive or negative.
As with their effect on DCs, the effect of NK cells on T cell responses can also be positive
or negative. Recent data show virus-specific CD4+ and CD8+ T cell responses are
negatively regulated by NK cells through perforin-dependent mechanisms (19-21).
Additionally, the elimination of certain surface molecules, including Qa-1 on T cells or 2B4
on NK cells, enhances NK cell-mediated regulation of T cell responses, presumably through
direct lysis of activated T cells by NK cells (22, 23). Other studies have implicated NKG2D
receptor signaling in the lysis of activated T cells (24-26). In addition to direct lysis, NK cell
acquisition of MHC-II molecules following DC interactions has been shown to down-
regulate CD4 T cell responses (27). NK cells produce IL-10 and TGFβ, which have negative
effects on T cell activation (28-30). However, NK cells also produce cytokines, such as
IFNγ, that enhance T cell responses (31, 32). In addition to these mechanisms of NK cell
regulation of T cell responses, the effects of NK cells on DCs will subsequently impact T
cell activation. Thus, NK cell functions span innate immune defense and primary adaptive
immune responses to infection.
During chronic LCMV infection, there is a generalized immune suppression mediated by
impaired antigen presentation and immune-mediated destruction of DCs (33-35). In addition
to the decrease in DC number, there is also a loss in their ability to stimulate an allogeneic
mixed lymphocyte reaction as early as 3 days post-infection (36). Later during persisting
virus infections in mice and in man, virus-specific T cells undergo significant decline in
number, while those that remain are retained in a dysfunctional state (37). These populations
of exhausted virus-specific CD8+ T cells are characterized by poor cytokine output,
cytolytic activity, and impaired proliferative capacity (38). The dysfunctional (exhausted)
cells are actively inhibited by signals transmitted through surface receptors PD1, Lag3,
Tim-3, CD160, and 2B4 and by the cytokine IL-10 (38, 39). Given the regulatory functions
of NK cells described above, it is plausible that NK cell activity may directly influence
virus-specific T cell responses or contribute to the loss in DC number or effectiveness and
affect viral control during a persisting virus infection.
Herein, we examined the role of NK cells in mice that were either acutely infected with
LCMV-Armstrong or given a disseminating infection with LCMV-Clone13. We found that
the depletion of NK1.1+ cells in acutely infected mice minimally impacted the magnitude of
primary T cell responses. However, NK cell-depletion had a remarkable protective effect
during disseminating virus infection: depleted mice showed greater than normal virus-
Cook and Whitmire Page 2













specific T cell responses that were protected from exhaustion and sustained across time.
This effect coincided with an increase in the stimulatory capacity of APCs isolated from
infected mice that were depleted of NK cells and ultimately resulted in an increased rate of




C57BL/6 mice were purchased from Jackson ImmunoResearch Laboratory. P14 TCR-
transgenic mice specific for the LCMV epitope GP33–41 (40) were crossed to C57BL/
6.Thy1.1 mice to generate TCR-transgenic Thy1.1+ mice. The depletion of NK cells was
accomplished by intraperitoneal administration of 2 doses of 75 μg NK1.1 - PK136 (Bio ×
Cell) on successive days; control mice were administered either 2 doses of 75 μg rat IgG2a
isotype control or PBS. Armstrong and Clone13 strains of LCMV were prepared and
quantitated as described previously (41). Mice were infected by intravenous administration
of 2 × 106 plaque forming units of Clone13 or Armstrong, or intraperitoneal administration
of 2 × 105 plaque forming units of Armstrong. Infectious LCMV in serum, liver, lung, and
kidney was quantified by plaque assay on Vero cell monolayers as described previously
(41). All mouse experiments were approved by the University of North Carolina-Chapel Hill
Institutional Animal Care and Use Committee.
Flow cytometry
Spleen cells were stained directly ex vivo with antibodies against CD8 (53-6.7), CD4
(RM4-5), NK1.1 (PK136), CD49b (DX5), CD44 (IM7), CD62L (MEL-14), CD3 (17A2),
CD11c (N418), CD11b (M1/70), SiglecH (551), PDCA-1 (927), PD-1 (RMP1-30), Lag-3
(C9B7W), CD244 (m2B4(B6)458.1), KLRG-1 (2F1/KLRG1), CD127 (LG.3A10), and
Thy1.1 (eBioscience, HIS5.1) antibodies. The intracellular cytokine staining (ICCS) assay
was performed as described previously (32). In brief, splenocytes were stimulated ex vivo
with LCMV peptide GP33-41 or GP61-80 for 5-6 hours in the presence of brefeldin A,
followed by surface staining for CD8 (or CD4) and Thy1.1, fixation, permeabilization, and
staining for IFN-γ, TNF, and IL-2. Granzyme B (GB11) staining was also performed after
fixation and permeabilization. All antibodies were from Biolegend, except where indicated.
Cell staining was analyzed by four-color flow cytometry using a BD Biosciences
FACSCALIBUR and analyzed by FlowJo software (www.treestar.com).
In vitro T cell stimulation
APCs were isolated from spleens that were lightly smashed in petri dishes and then
incubated at 37° for 30 minutes in media supplemented with 1 mg/mL collagenase I
(Calbiochem) and 10 μg/mL DNAse I (Sigma) before being forced through a mesh filter.
P14 T cells were isolated from spleens of P14-transgenic mice and labeled with 2 μM CFSE.
The APCS and T cells were mixed at a ratio of 20:1 and incubated for 5 days before
measuring CFSE dilution by flow cytometry.
Statistics
Statistical analyses were performed using Prism software (www.graphpad.com), employing
an unpaired two-tailed Student's t-test to evaluate the significance of differences between
groups.
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NK cells are more active during chronic virus infection than acute infection
C57BL/6 mice that are infected with LCMV-Armstrong (Armstrong) develop an acute
infection that is resolved within one week by expanded populations of virus-specific CD8+
T cells. In contrast, mice given LCMV-Clone13 (Clone13) – a variant that replicates rapidly
and spreads widely – develop a persisting infection that lasts for 2 to 3 months. While much
energy has been focused on understanding the T cell response to these viruses, a full
characterization of the NK cell response is lacking. Therefore, we followed NK cell
frequencies in the spleen and blood at different times after infection. The NK cell number in
the spleen decreased 2-fold by day 8 in acutely infected mice and began declining by day 3
in Clone13 infected mice and reached a 4-fold decrease by day 8 (Fig. 1A). In contrast to the
spleen, NK cell frequencies increased in the blood after Clone13 infection at 7 days post-
infection (Fig. 1B), whereas the frequency of NK cells in the blood after acute infection did
not change compared to uninfected mice. At days 14 and 21 after infection, the frequency of
NK cells in the blood of the Clone13 group remained higher than in the Armstrong group.
The frequency of NK cells in Clone13-infected mice eventually returned to pre-infection
levels, while NK cell frequencies in Armstrong-infected mice was reduced below this level
(Fig. 1B). The reduced NK cell frequency observed between days 7 and 14 in both
infections may be due to the massive influx of activated T cells into the blood between these
time points. To determine if the cells are functionally altered by viral persistence, we
measured the expression level of Granzyme B, a mediator of cytotoxicity. During an acute
infection, the Granzyme B level rapidly increased by day 3 but then decreased to near
baseline levels afterwards (Figs. 1C & 1D). The level of Granzyme B expression also
peaked at day 3 during a Clone13 infection, but the level was higher than during an
Armstrong infection (Figs. 1C & 1D). Additionally, the increase in Granzyme B expression
level was maintained for a longer amount of time during chronic infection, through day 20
(Figs. 1C & 1D). To determine if this increase in NK cell activation was associated with an
increase in maturation, we measured the expression of CD11b and CD27 on NK cells (42).
Uninfected mice had nearly equal populations of CD11blow, DP, and CD27low NK cells, and
both Armstrong and Clone13 infections induced maturation of a majority of the splenic NK
cells into the CD27low subset by day 7 post-infection (Fig. 1E). An additional marker of NK
cell maturation, KLRG-1 (43), was also increased on blood NK cells shortly after Armstrong
and Clone13 infections, and the enhanced frequency of KLRG-1+ NK cells was maintained
for a longer time in Clone13-infected mice (Fig. 1F). Thus, there is a correlation between the
persistence of infection and the frequency, activation status, and maturity of NK cells for
multiple weeks.
NK cells are capable of either promoting or inhibiting adaptive immune responses to
infection. While some data indicate that NK cells promote T cell responses, multiple recent
papers have suggested that NK cells limit T cell responses by inducing perforin-mediated
cell death of activated T cells or APCs (18-21, 23, 44). To determine what effect NK cells
have on T cell responses during acute and chronic viral infection, we depleted NK cells
using the NK1.1 (PK136) antibody. The antibody treatment specifically eliminated NK cells
quickly and was durable (Fig. S1). We considered that NK1.1 expression might be induced
on non-NK cells during infection. However, we found that NK1.1 expression was restricted
to DX5+ NK cells (Fig. S1A) and <1.5% of T cells, B cells, T-reg cells, or DC (Fig. S1C),
indicating that NK1.1 antibody treatment is unlikely to deplete potential targets of LCMV
infection (33). We confirmed that the antibody treatment did not change the number of
CD4+FoxP3+ T reg cells before infection (Fig. S1D).
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NK cells limit early CD8+ T cell responses to a disseminating virus infection
To further understand how NK cells affect a defined population of virus-specific CD8+ T
cells after an acute or chronic virus infection, we adoptively transferred a small number of
naïve LCMVGP33-41-specific TCR-transgenic P14 cells prior to infection. The mice were
subsequently given the NK1.1 or control antibody and the P14 cell response was analyzed
by flow cytometry at day 8 of the infection. For uninfected control mice, much larger
numbers of P14 cells were given to facilitate their detection; in the absence of infection
these P14 cells retained their naïve phenotype (CD62Lhi, CD44lo) following the adoptive
transfer (data not shown). The mice that were treated with NK1.1 but left uninfected had
similar frequencies of P14 cells in the spleen compared to control-treated recipients,
indicating that NK cell-depletion does not affect the engraftment of P14 cells (Fig. 2A). The
control and NK1.1-treated mice that were given Armstrong showed a vigorous expansion of
the P14 and endogenous CD8+ T cells with little difference between the 2 groups (Fig. 2A
and data not shown). As expected, in the control treated mice there was a lower level of
expansion by the P14 cells in Clone13 compared to Armstrong infected mice (Fig. 2A).
However, the Clone13 infected mice that were depleted of their NK cells showed a
pronounced increase in the frequency of P14 cells (Fig. 2A). Based on the total cell counts,
NK cell depletion resulted in a modest increase in P14 cells in Armstrong-infected mice and
a 3-fold increase in the Clone13-infected mice (Fig. 2B), which became similar in
magnitude to the number seen in acutely infected mice.
The ability of virus-specific CD8+ T cells to express cytokine upon exposure to peptide was
examined by intracellular cytokine staining followed by flow cytometry analysis. There was
no detectable IFNγ or TNF expression by the P14 cells in uninfected mice; however, by 8
days post Armstrong infection >70% of the P14 cells expressed IFNγ and TNF when
exposed to cognate peptide (Fig. 2C). In Clone13-infected mice, only 20% of the P14 cells
produced both cytokines, consistent with cells that are exhausted (38), while the depletion of
NK cells increased the frequency of IFNγ+TNF+ double-positive P14 cells (Fig. 2C). In
both Armstrong and Clone13-infected mice, the depletion of NK cells increased the total
number of IFNγ+TNF+ cells, but the effect was greatly exaggerated in the Clone13-infected
mice (Fig. 2D). The nearly 10-fold increase in IFNγ+TNF+, as well as IFNγ+IL-2+, P14
cells seen after NK depletion in Clone13-infected mice resulted in cell numbers matching
those seen in the Armstrong-infected mice. NK cell depletion also increased the frequency
and number of endogenous polyclonal virus-specific CD8+ T cells by 4 to 15-fold in
Clone13-infected mice (Fig. S2), indicating that NK cell-depletion enhances multiple
populations of cells and is not unique to the P14 cells or the GP33-41 specificity.
Because NK cell depletion leads to greater numbers of virus-specific CD8+ T cells that are
capable of producing multiple cytokines that broadly enhance immune system activation
(IFNγ, TNF) and drive T cell memory (IFNγ, IL-2) at the peak of the response, we
considered that NK cell depletion might have lasting effects on virus-specific T cell
abundance. Indeed, the percentage of P14 cells in Clone13-infected mice was enhanced by
4-fold at day 14 in mice depleted of NK cells (Fig. 2E). After day 14, the P14 response
contracted in the Clone13-infected mice, but the NK cell-depleted mice continued to have
11-fold higher frequencies of P14 cells than control-treated mice at day 28. These data show
that the depletion of NK cells results in vigorous CD8+ T cell responses that are sustained
across time during persisting infection.
It has been suggested that the effect of NK cell depletion on CD8+ T cell activity during a
chronic viral infection is due to a defect in the CD4 response caused by direct NK cell-
mediated killing of activated CD4+ T cells (20). To test this hypothesis, we measured the
endogenous CD4+ T cell responses during acute and chronic infections after NK cell
depletion. The majority of endogenous CD4+ T cells in uninfected mice express the naïve
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(CD62Lhi/CD44lo) surface phenotype, while a high proportion in Armstrong infected mice
express the activated (CD62Llo/CD44hi) surface phenotype, with no differences seen in
either condition following the depletion of NK cells (Fig. 2F). The frequency of activated
CD4+ T cells in control-treated Clone13 infected mice resembled uninfected mice; however,
the depletion of NK cells increased the percentage of activated CD4 cells to a level similar
to that in Armstrong infected mice (Fig. 2F). To confirm that the global effect on CD4
activation accurately reflects the LCMV-specific CD4+ T cell response, we measured the
frequency of CD4+ T cells specific for LCMV by intracellular cytokine staining after
stimulation with the immunodominant LCMVGP61-80 peptide. The depletion of NK cells had
very little effect in Armstrong-infected mice, yet the number of LCMV-specific IFNγ
producing CD4+ T cells was significantly enhanced in the absence of NK cells in Clone13-
infected mice (Fig. 2G). These data indicate that both the CD4+ and CD8+ T cell responses
are significantly improved by the depletion of NK cells during chronic LCMV infection.
NK cell depletion reduces the expression of T cell exhaustion markers
During persisting virus infections, virus-specific T cells are held in an inactive state due to
their expression of inhibitory surface molecules, including PD-1, Lag-3, and 2B4, and
interactions with corresponding ligands on APCs (45). Given the data in Figure 2 showing
reduced frequencies of virus-specific cytokine producing CD8+ T cells during Clone13
infection and the well-characterized exhaustion phenotype observed with this infection, we
next examined whether NK cell depletion affected the expression of these exhaustion
markers on CD8+ T cells. The P14 CD8+ T cells did not express detectable levels of PD-1
or Lag-3 in uninfected mice (Fig. 3A). At day 8 post-infection, only a small population of
the P14 cells expressed these markers in Armstrong-infected mice, but 80% of the P14 cells
expressed PD-1 at this time in Clone13-infected mice and 30% were double positive for
PD-1 and Lag-3 (Figs. 3A & 3B), consistent with a significant functional exhaustion.
Minimal levels of 2B4 were expressed on the P14 cells in uninfected or day 8 Armstrong-
infected mice; however, half of the P14 cells expressed 2B4 in control-treated Clone13-
infected mice (Fig. 3B). The depletion of NK cells prior to Clone13 infection significantly
reduced the percentage of P14 cells expressing PD-1, Lag-3, and 2B4 (Figs. 3A & 3B).
Thus, NK cell depletion reduces the percentage of virus-specific CD8+ T cells that express
the inhibitory receptors associated with T cell exhaustion early after infection.
T cell exhaustion is typically analyzed several weeks after infection. To evaluate if NK cell
depletion had durable effects on T cell exhaustion, sets of mice were infected with Clone13
and, across several weeks, PBLs were isolated and the P14 cells were stained for exhaustion
markers. The percentage of cells that expressed PD-1, Lag-3, and 2B4 were consistently
reduced in Clone13-infected mice that were depleted of NK cells (Fig. 3C), and the per-cell
level of PD-1, Lag-3, and 2B4 on these cells was reduced as indicated by geometric mean
fluorescence intensity (data not shown). The ability of the P14 cells to produce cytokines
was determined 4 weeks after infection. Few of the P14 cells from Clone13-infected mice
were able to produce both IFNγ with TNF or IL-2 at day 29, which is consistent with the
exhausted phenotype (Fig. 3D). However, elevated percentages of P14 cells from NK-
depleted mice vigorously produced multiple cytokines at this time (Fig. 3D). Moreover, the
overall number of P14 cells capable of producing these cytokines was enhanced >55-fold in
mice depleted of NK cells compared to control-treated mice (Fig. 3E). These data indicate
that NK cell-depletion limits the formation of cells with well-established phenotypic and
functional characteristics of exhaustion.
To determine the kinetic window for the effect of NK cell depletion on T cell exhaustion, we
performed the NK antibody treatment at various times after infection. We measured P14 T
cell number and function at day 8 in mice that were given NK1.1 at day 0, 2, or 4 (Fig. 4).
Surprisingly, initiating NK cell depletion at 2 or 4 days post-infection had very little impact
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on the CD8+ T cell response: both the number of P14 cells (Figs. 4A & 4B) and their ability
to produce IFNγ and TNF (Figs. 4C & D) were unaffected by the post-infection antibody
treatment, despite efficient NK cell depletion (data not shown). Consistent with these results
at day 8, the long-term effects on T cell exhaustion and cytokine production at day 29 were
also not affected when NK1.1 was delayed to day 4, 7, 11, or 14 after infection (data not
shown). The endogenous CD4+ T cell response was rescued when NK cell depletion began
at day 0 or day 2 but not on day 4. Both the frequency of activated cells and the number of
LCMV-specific IFN-γ positive CD4+ cells were improved by NK1.1 antibody treatment on
day 2 but not after (Figs. 4E & 4F). Taken together, these data indicate that inhibition by NK
cells occurs before day 2 for CD8+ T cells and before day 4 for CD4+ T cells, despite the
fact that NK cells are activated for a prolonged period in Clone13-infected mice.
NK cells negatively regulate APC stimulatory capacity and viral clearance
The brief period when NK cell depletion affects CD8+ T cell responses suggests that NK
cells target DCs, which are responsible for initiating T cell stimulation. Consistent with this
idea, NK cells directly lyse DCs during MCMV infection to restrict subsequent T cell
activation (44). Therefore, we measured the number of DCs after Clone13 infection in the
presence or absence of NK cells. The total number of splenic DCs (Fig. 5A), as well as the
CD11b+, CD8+, CD4+, and plasmacytoid DC subsets (Figs. 5B-5E), rapidly decreased in
the first few days after Clone13 infection. However, there was no difference between the
control- and NK1.1-treated mice. Additionally, the DC expression levels of the stimulatory
receptors MHC-I/II, the costimulatory receptors B7-1/2, and the inhibitory receptors
PDL-1/2 were not altered by NK cell depletion (Fig. S3). Taken together, these data indicate
that NK cells do not impact the overall number or surface stimulatory profile of DCs.
The previous data do not account for NK cell effects on the presentation of LCMV-specific
epitopes; therefore, we developed an in vitro stimulation assay to test whether APC
stimulation of T cell proliferation is altered by the presence or absence of NK cells.
Splenocytes from NK-depleted or control-treated Clone13 infected mice were assessed for
their capacity to stimulate CFSE-labeled naïve P14 cells. In control-treated mice, the highest
level of CFSE dilution occurred using APCs from day 1 post-infection, while cells from
uninfected mice did not stimulate proliferation in the absence of added peptide (Fig. 6). The
stimulatory capacity of the splenic APCs underwent a significant decline by days 2 and 3
post-infection (Fig. 6), which parallels the decrease in the number of DCs shown in Figure
5. In NK cell-depleted mice, APCs from uninfected mice stimulated minimal P14 cell-
division and APCs from day 1 induced strong proliferation, similar to that induced by
splenocytes from the control-treated mice at those times (Fig. 6). However, APCs isolated
on days 2 & 3 of infection from NK cell depleted mice stimulated a significantly higher
level of CFSE-dilution compared to day 2 & 3 cells from control-treated mice (Fig. 6). The
inclusion of cognate peptide to the cultures induced maximal levels of T cell division,
regardless of which APC population was used (Fig. 6B), which suggests that APCs from
each day are potentially capable of promoting T cell proliferation, but NK cells limit the
stimulation of T cells by LCMV-infected APCs. These data indicate that the ability of APCs
from infected mice to stimulate LCMV-specific T cell proliferation is sustained when NK
cells are depleted.
NK cells limit early acute virus infection by killing virus-infected target cells; however, our
data indicate that NK cells restrict the ability of APCs to stimulate T cell proliferation (Fig.
6) and decrease the magnitude and function of virus-specific CD8+ T cells during a highly
disseminated infection (Figs. 2 & 3). To determine if these effects alter viral clearance, the
viral loads were measured in control or NK cell-depleted mice at different times after
Clone13 infection. The viral titers in the lung, liver, and kidney at day 3 post-infection (Fig.
7), as well as at days 1 and 2 (data not shown), were overlapping between the control and
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NK-depleted mice. This indicates that the differences observed in the in vitro stimulation
assay (Fig. 6) were not caused by major changes in the viral load. Along this line, NK
depletion had no effect on the initial Armstrong titers at day 3 or viral clearance by day 8
(data not shown), consistent with earlier reports (46, 47). At day 8 of Clone 13 infection,
there remained high viral loads in all mice, but there was a significant reduction in the NK
cell-depleted mice in the liver, lung and kidney compared to the control treated mice (Fig.
7). By day 29, all of the control-treated mice continued to harbor 104-106 PFU/gram tissue
of virus; however, in all of the tissues measured at least 7 of 9 mice treated with NK1.1
reduced viral loads to near or below detection, which represents a 100- to 10,000-fold
reduction in viral burden (Fig. 7). These findings show that the depletion of NK cells before
infection does not impact the early replication of LCMV, however, there is a dramatic
enhancement in the subsequent antiviral CD8+ T cell response that accelerates the control of
this disseminating virus infection.
Discussion
Overall, these results show that NK cells negatively regulate adaptive T cell responses to
persisting virus infection; T cell activity is significantly increased by NK cell depletion
during persistent infection while only marginally affected during acute infection. We also
detect an increase in the stimulatory capacity of APCs from infected NK cell-depleted mice.
We propose that NK cell depletion enhances APC functions to improve subsequent T cell
responses and control of the infection.
The interactions between NK cells and DCs can have either positive or negative effects on
the subsequent priming of T cell responses. These interactions have been shown to activate
NK cells, alter NK and DC cytokine production, increase DC maturation, decrease antigen
presentation, or result in DC lysis. The outcome of these interactions can be influenced by
the differentiation status of the cells or the NK-DC ratio, as well as the type of infection or
strain of virus (6, 48). For example, during Smith strain MCMV infection, NK cells promote
CD8 T cell responses by limiting the viral load and preserving the DC frequency (18);
however, during K181-Perth MCMV infection, NK cells limit the ability of T cells to
control a chronic infection by reducing the availability of infected APCs for T cell priming
(44). Our data indicate that NK cell depletion did not increase either the DC number or their
expression of MHC and B7 molecules or decrease expression of PDL molecules (Fig. 5 &
Fig. S3). However, the ability of these APCs to stimulate CD8 T cell proliferation was
severely blunted by the presence of NK cells (Fig. 6), and preliminary experiments indicate
that NK cells also reduce the ability of APCs to stimulate CD4 T cell proliferation (data not
shown). The main APC population responsible for stimulating T cell proliferation early after
infection appears to be CD11c+CD8+ DCs (data not shown), and we are currently
investigating whether NK cell-depletion specifically affects this population of cells. The
ability of NK cells to alter the APC stimulatory capacity could be mediated by multiple
different mechanisms. Perhaps, NK cells reduce the production of cytokines by APCs that
either favor T cell stimulation, such as IL-12, or increase those that inhibit T cell
proliferation, such as IL-10. Additionally, the trans-presentation of IL-15 by DCs is crucial
for both NK and T cell responses (11, 49). The removal of NK cells may increase the
availability of IL-15 (or perhaps IL-2 and IL-7) to support T cell accumulation. Another
possibility is that even though the overall level of surface MHC-I expression is not affected
by NK cell depletion, the proportion of MHC molecules bearing LCMV epitopes could be
altered to better stimulate T cells. Further experiments are needed to distinguish between
these possibilities.
In addition to the ability of NK cells to indirectly regulate T cell responses through effects
on APCs (Fig. 6), NK cells can also directly impact T cell activity. Activated T cells can be
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direct targets of NK-mediated lysis (24). CD4+ T cells are crucial for sustaining CD8+ T
cell responses during chronic virus infection (50), and some evidence indicates that NK cells
focus perforin-mediated cytolysis against activated CD4 T cells, which ultimately causes
defects in the CD8+ T cell response to LCMV (20). While NK cells are capable of killing
activated CD8+ T cells, this appears to be prevented by the interaction between CD48 on the
T cells and 2B4 on the NK cells (23). We see greatly enhanced numbers of activated CD4+
T cells and LCMV-specific cytokine positive CD4+ T cells when NK cells are depleted
prior to infection (Fig. 2), consistent with the idea that activated CD4 T cells are direct
targets of NK cell-mediated cytotoxicity. However, we believe that this is not the sole
mechanism for NK cell regulation of the CD8 response. Our results (Fig. 4) show that
delaying NK cell depletion until 2 days after infection enhances CD4 T cell activation and
cytokine production, yet the CD8 T cell response is not rescued in the presence of greater
numbers of virus-specific CD4+ T cells. These data indicate that NK cell effects on CD8 T
cells can occur independently of NK cell effects on CD4 T cells.
A hallmark of persistent viral infections is the establishment of the exhausted T cell
phenotype, wherein T cells are maintained in a state of inactivity. Typically, this is thought
to occur late during the infection after the T cells have been repeatedly exposed to antigen.
Surprisingly, the effect of NK cells on CD8+ T cell responses occurs before day 2, which is
before endogenous virus-specific T cells commence cell division and become detectable (51,
52). This is consistent with NK cells impairing APC-mediated induction and early
propagation of the T cell response and implies that the exhaustion phenotype can be
programmed early during infection. Therefore, NK cells can promote T cell exhaustion by
modifying the APCs that initiate T cell responses.
NK cells may have evolved dual functions to protect the host during infection: directly
fighting against infection on the one hand (48) and controlling detrimental immune-
mediated pathogenesis on the other. In contrast to the expected antiviral role of NK cells
during virus infection, the removal of NK cells had no effect on the initial levels of LCMV
replication. However, NK cell restriction of the CD8 T cell response permitted lengthy
chronic infection (Fig. 7). Interestingly, the extent of NK-mediated regulation of CD8 T
cells varied by the chronicity of the virus: T cell activity was significantly increased by NK
cell depletion during persistent infection while only marginally affected during acute
infection. This ability of NK cells to limit T cell activity may function to thwart
immunopathology when infections are widely disseminating. If unchecked, the continuous
production of viral antigens during persistent infection would stimulate T cells to destroy
vital tissues. Therefore, the balance between NK cells directly fighting virus infection versus
limiting antiviral T cell responses can be crucial in determining the survival of the host.
In summary, we confirm that the removal of NK cells greatly increases the quantity and the
cytokine output of the CD8 T cell response (20, 21). Additionally, we show that these
effects on CD8+ T cells are long-lasting and establish that NK cells contribute to T cell
exhaustion. Our data demonstrate that the major effect of NK cells on CD8+ T cell
responses occurs within the first 2 days of infection. The NK cell-mediated regulation of
CD8 cells is accomplished by a combination of effects, and we reveal that a major
mechanism involves limiting the ability of APCs to stimulate T cell proliferation. This
ability of NK cells to diminish T cell responses implies that the elimination of NK cells may
have potential in improving the success of vaccination, while promoting NK cell activity
may be beneficial in protecting against immune-mediated disorders.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. NK cell number during acute and chronic virus infection
Adult B6 mice were infected with the Armstrong or Clone 13 strain of LCMV. A) At days 0,
3, and 8 post-infection (pi), splenocytes were harvested, stained for NK cell markers, and
analyzed by flow cytometry. The total number of NK1.1+ DX5+ NKp46+ splenic NK cells
at the indicated days is depicted as mean + SEM, with N=4-13 over 5 experiments for
Armstrong, and N=12-16 over 6 experiments for Clone13. The significant differences
between the Armstrong and Clone13 infected mice relative to the uninfected samples are
indicated. B) The frequency of NK cells within peripheral blood leukocytes was measured in
mice bled repeatedly over time and is depicted as mean +/- SEM, with N=3-11 over 4
experiments for Armstrong, and N=6-10 over 4 experiments for Clone13. The asterisks
indicate differences between Armstrong and Clone13 at each time. C-D) NK cells isolated
from the blood were intracellularly stained for Granzyme B. The histograms show examples
of the Granzyme B levels in NK cells from uninfected (shaded), Armstrong infected (thin
line), and Clone 13 infected (thick line) mice at various time points after infection (C). The
line graph shows the gMFI of Granzyme B in NK cells from each group over time, depicted
as mean +/- SEM, with N=4 for each group from 2 experiments (D). E) NK cells isolated
from the spleen at day 7 pi were stained for CD11b and CD27; the numbers indicate the
frequency of NK cells within each quadrant. The dot plots are representative of 3 mice from
1 experiment. F) NK cells isolated from the blood were stained for KLRG-1. The line graph
shows the percentage of NK cells that are KLRG-1 hi over time, depicted as mean +/- SEM,
with N=3 from 1 experiment. Significant differences between Armstrong and Clone13 at
each time are indicated by asterisks: * p<0.05, ** p<0.01, *** p<0.001.
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Figure 2. NK cell depletion improves early T cell responses to chronic virus infection
2×103 P14 T cells from Thy1.1+ mice were transferred to Thy1.2+ B6 mice; the mice were
treated with NK1.1 or control antibody at days -2 & -3 and then infected with LCMV-
Armstrong or Clone13. Uninfected mice were given 2×106 P14 T cells to facilitate the
detection of P14 cells. A) The dot plots identify P14 T cells in the spleens from uninfected
mice or mice 8 days after infection; the numbers indicate the frequency of CD8+ Thy1.1+
P14 cells among all spleen cells. B) The total number of CD8+Thy1.1+ splenic P14 cells at
day 8 pi, depicted as mean + SEM, with N=3 from 1 experiment for Armstrong, and
N=11-14 over 5 experiments for Clone13. C) An example of IFNγ and TNF production by
splenic P14 cells at day 8 pi after ex vivo stimulation with LCMV peptide GP33-41; the
numbers above each plot indicate the percentage of IFNγ+TNF- and IFNγ+TNF+ cells
among P14 cells. D) The total number of IFNγ+TNF+ (top) or IFNγ+IL-2+ (bottom) splenic
P14 cells at day 8 pi, depicted as mean + SEM, with N=3 from 1 experiment for Armstrong,
and N=11-14 over 5 experiments for Clone13. E) The frequency of P14 cells among blood
leukocytes in mice that were bled repeatedly following infection with LCMV-Clone13
(mean +/- SEM; N = 6-10 from 4 experiments). F) CD4+ T cells from the spleen were
stained for the activation markers CD62L and CD44. The numbers indicate the percentage
of CD4 cells in each quadrant. G) The total number of IFNγ+ splenic CD4 cells at day 8 pi,
as measured by intracellular cytokine staining, depicted as mean + SEM, N=6 for Armstrong
across 2 experiments and N=11-14 across 5 experiments for Clone13. The asterisks indicate
significant differences between control and NK1.1-treated groups: * p<0.05, ** p<0.01, ***
p<0.001.
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Figure 3. NK cell depletion reduces T cell exhaustion during chronic virus infection
2×103 P14 T cells from Thy1.1+ mice were transferred to Thy1.2+ B6 mice; the mice were
treated with NK1.1 or control antibody at days -2 & -3 and then infected with LCMV-
Armstrong or Clone13. A-B) On day 8 post-infection, spleen cells were harvested and
analyzed for several markers of exhaustion. A) Representative dot plots show the expression
of PD-1 and Lag-3 on P14 T cells, while the numbers indicate the frequency of cells in each
quadrant. B) Cumulative data are depicted by the bar graphs, which show the percent of
splenic P14 cells that stained positive for PD-1 (left), Lag-3 (center), and 2B4 (right),
represented as mean + SEM, with N=3 from 1 experiment for Armstrong and N=9-14 across
5 experiments for Clone13. C) The percent of peripheral blood P14 cells that stained
positive for PD-1 (left), Lag-3 (center), and 2B4 (right) at various days after infection is
depicted as mean +/- SEM, N=6 for each group from 2 experiments. D) An example of IFNγ
and TNF (left) or IL-2 (right) production by splenic P14 cells at day 29 pi after ex vivo
stimulation with LCMV peptide GP33-41; the numbers above each plot indicate the
frequency of IFNγ+TNF- and IFNγ+TNF+ or IFNγ+IL-2- and IFNγ+IL-2+ P14 cells. E)
The total number of IFNγ+TNF+ or IFNγ+IL-2+ splenic P14 cells at day 29, depicted as
mean + SEM with N=8-9 over 3 experiments. Significant differences between control and
NK1.1-treated samples are indicated: * p<0.05, ** p<0.01, *** p<0.001.
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Figure 4. The effects of NK cell depletion on T cells occur early after infection
2×103 P14 T cells from Thy1.1+ mice were transferred to Thy1.2+ B6 mice; the mice were
treated with control antibody or NK1.1 on either days 0, 2 or 4 of the infection with LCMV-
Clone13. A) The dot plots identify P14 T cells in the spleens of mice 8 days after infection;
the numbers indicate the percentage of CD8+ Thy1.1+ P14 cells among all spleen cells. B)
The total number of CD8+Thy1.1+ splenic P14 cells at day 8 pi, depicted as mean + SEM,
N=4-7 for each group over 3 experiments. C) An example of IFNγ and TNF production by
splenic P14 cells at day 8 pi after ex vivo stimulation with LCMV peptide GP33-41; the
numbers above each plot indicate the percentage of IFNγ+TNF- and IFNγ+TNF+ cells
among P14 cells. D) The total number of IFNγ+TNF+ splenic P14 cells at day 8 pi, depicted
as mean + SEM, N=4-7 for each group over 3 experiments. E) CD4+ T cells from the spleen
were stained for the activation markers CD62L and CD44. The numbers indicate the
frequency of CD4 cells in each quadrant. F) The total number of IFNγ+ splenic CD4 cells at
day 8 pi, as measured by intracellular cytokine staining, depicted as mean + SEM, n=4-7 for
each group over 3 experiments. Significant differences between day 0 NK1.1 treatment and
all other samples are indicated: * p<0.05, ** p<0.01.
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Figure 5. NK cell depletion does not affect the number of splenic DCs
Adult B6 mice were infected with LCMV-Clone13. At days 0, 1, 2, and 3 after infection,
splenocytes were harvested, stained for DC cell markers, and analyzed by flow cytometry.
The dot plots shows examples of the staining used to identify CD11c+CD3- DCs (A),
CD11b+ DCs (B), CD8+ DCs (C), CD4+ DCs (D), and pDCs (E). Samples A and E depict
all spleen cells, while samples B, C, and D were gated on CD11c+CD3- DCs. The bar
graphs display the total number of the indicated DC subsets and are depicted as mean +
SEM, N=3-8 for each group over 3 experiments.
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Figure 6. APCs from infected mice depleted of NK cells show improved capacity to stimulate T
cell proliferation
Naïve P14 T cells from Thy1.1+ mice were stained with CFSE and incubated with
splenocytes from day 0, 1, 2, or 3 LCMV-Clone13 infected B6 mice at a ratio of 1:20. The
splenocytes were from mice that had been treated with NK1.1 or control antibody at days -2
& -3 before infection. A) The histograms are gated on the CD8+Thy1.1+ P14 cells and show
their dilution of CFSE on day 5 of the in vitro culture. The numbers indicate the percentage
of P14 cells that had divided more than once. B) The bar graphs display the percentage of
the P14 cell population that had divided in the absence of exogenous peptide and is depicted
as mean + SEM, N=3-5 for each group over 3 experiments. The short lines above each bar
indicate the percentage of divided cells after addition of 1 μM of LCMV peptide GP33-41 at
the beginning of the culture. The asterisk indicates a significant difference (P<0.05) between
control and NK1.1-treated samples.
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Figure 7. The depletion of NK cells improves viral clearance
2×103 P14 T cells from Thy1.1+ mice were transferred to Thy1.2+ B6 mice; the mice were
treated with NK1.1 or control antibody at days -2 & -3 and then infected with LCMV-
Clone13. The level of virus infection was determined by plaque assay from (A-C) liver,
lung, and kidney tissues isolated from mice harvested on days 3, 8, or 29 pi and (D) serum
samples isolated from mice bled repeatedly over time. The solid line shows the average
titers for each group; the dashed line represents the limit of detection. Significant differences
between control and NK1.1-treated samples are indicated: * P<0.05, ** P<0.01 (N=7-11
over 4 experiments in A-C ; N=3-5 over 2 experiments in D).
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